Why These 3 TSX Stocks Rallied on Wednesday

Let’s take a look at why the shares of Torex Gold Resources’ (TSX:TXG), Aurora Cannabis (TSX:ACB)(NYSE:ACB), and B2Gold (TSX:BTO) rallied on June 24.

| More on:
Business man on stock market financial trade indicator background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

After trading on a positive note in the last couple of days, the S&P/TSX Composite Index turned negative again on Wednesday. Today’s pessimism could primarily be attributed to a record rise in COVID-19 cases in many U.S. states. Fears surrounding the second wave of the pandemic hurt investors’ sentiments, driving the stock market lower today — especially energy stocks.

Nonetheless, many stocks were still trading on a positive note this morning. Let’s take a closer look at three of these top TSX movers today and try to find out what helped them swim against the current.

Torex Gold Resources surged 7%

Torex Gold Resources’ (TSX:TXG) stock inched up by 7% this morning after TD Securities started its coverage with a “buy” rating. The Canadian investment bank gave a price target of $30 on Torex Gold’s stock.

Currently, nine analysts are covering Torex Gold Resources with a consensus target price of $28.73. This target price reflected more than 52% upside potential in Torex Gold’s stock from its Tuesday’s settlement price of $18.87. Of these nine analysts, only one analyst is giving it a “hold,” while all the remaining eight analysts suggest a “buy.”

On June 5, the research firm BMO also raised its target on Torex Gold’s stock from $27 to $33. Notably, Torex Gold has reported over 40% revenue growth rate in the last couple of years.

Aurora cannabis rallied over 6%

Shares of Aurora Cannabis (TSX:ACB)(NYSE:ACB) — the Canadian marijuana company — climbed 6.5% earlier today. These massive gains were seen after two Wall Street analysts adjusted their recommendations and price targets on the company’s stock. Analysts at Stifel turned slightly optimistic on Aurora on Wednesday and changed their “sell” rating to a “hold” and raised their price targets to $17.50 from $6.20.

In contrast, Canaccord Genuity lowered its target price on Aurora Cannabis today to $21 from $24 earlier. These changes in ratings came after the cannabis company announced its key business transformation plan yesterday. Per the plan, Aurora Cannabis expects to reduce about 30% of its production staff over the next two quarters. These measures will help the company significantly reduce its costs and regain investors’ confidence.

Gold shining again

While the rising COVID-19 cases are taking a significant toll on investors’ sentiments across the world, these fears are also helping some companies attract more investors. For example, shares of B2Gold (TSX:BTO) rose by 1.5% Wednesday morning — before turning mixed again later in the session. The Canadian gold producer’s initial gains came as investors seemingly started seeking safer investment options.

In general, many investors tend to park their money in precious metals — especially in gold or related stocks — at the time of crisis — to avoid potential market risks. This is one of the reasons why B2Gold’s stock has zoomed up 72.3% in the second quarter so far.

Notably, its stock is also maintaining about 40.9% solid gains on a year-to-date basis against an 8.8% decline in the TSX Composite Index.

Overall, you can expect any upcoming COVID-19-related update to keep the stock market highly volatile and investors on their toes in the coming days as well. But don’t forget to strictly follow your risk management strategy while investing.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »